Comparison Chart Myriad Genetics, Inc.
Stocks
MYGN
US62855J1043
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.260 USD | +2.52% |
|
+13.99% | -46.99% |
| 07-31 | Myriad Genetics, Inc., Q2 2026 Earnings Call, Jul 30, 2026 | |
| 07-30 | Myriad Genetics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MYRIAD GENETICS, INC. | Diagnostic & Testing Substances | +2.52% | +13.99% | -46.99% | -46.56% | -90.54% | 312M |  | | |
- Stock Market
- Stocks
- MYGN Stock
- Charts Myriad Genetics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
